Delivery Order SPE2DB22D2211-SPE2DB25FSBSU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Voriconazole 200 mg tablets (30-count) with a ceiling value of $14,633.76. This firm fixed-price, competitively awarded contract was finalized on July 28, 2025, with an ultimate completion date of July 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order does not include a set-aside designation and represents a tactical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,683.31 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for 4,564,274,187 units of the pharmaceutical product VORICONAZOLE 200 MG TABLET 30S. This delivery order was issued against an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This federal contract award is for the delivery of VORICONAZOLE 200MG 30S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $76,883.53 and an ultimate completion date of July 11, 2017. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $27,094.95 firm fixed-price contract is for the delivery of VORANIGO 40 MG TABLET 30S, a pharmaceutical product, with a completion date of July 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,496.63 on July 28, 2025, with a completion date of July 29, 2025. This non-set-aside contract procures VEOZAH 45 mg tablets in a 30-count package under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,343.83, is for the delivery of VORANIGO 40 MG TABLET 30S, a pharmaceutical product. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $81,284.85, is for the delivery of 4,568,121,169 units of the medication "VORANIGO 40 MG TABLET 30S." The contract is a firm fixed-price, non-set-aside award with a performance period through May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $34,113.36 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of VYVGART 400 mg/20 mL vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBSUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Voriconazole 200 mg tablets in unit dose packages of 30 units. This contract, valued at $4,341.78, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 pharmaceutical prime vendor vehicle designated SPE2DX and running through December 2026. This comprehensive IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The award demonstrates the company's continued role as a critical supplier of essential medications to the federal health services community.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/28/25 |